mHealth for HIV Treatment & Prevention: A Systematic Review of the Literature.
mHealth for HIV Treatment & Prevention: A Systematic Review of the Literature.
复制标题
DOI：
10.2174/1874613620130812003
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
Israelski DM
中科院分区：
文献类型：
--
作者：
Catalani C;Philbrick W;Fraser H;Mechael P;Israelski DM
本系统性综述评估了已发表的文献，以描述用于艾滋病毒/艾滋病的移动的医疗技术（mHealth）的前景，以及支持使用这些工具解决艾滋病毒预防、护理和治疗级联的证据。创新的速度、广泛的举措和工具以及报告的多样性，使人们难以发现和综合关于移动保健工具如何有效应对艾滋病毒流行病的知识。为了弥补这一差距，一组评审人员在健康、工程和社会科学文献数据库中收集了关于使用移动的技术治疗艾滋病毒/艾滋病的文献，并分析了最终的62篇文章。文章被系统地编码，评估科学严谨性，并分类艾滋病毒方案的相关性。审查显示，有证据表明，移动保健工具支持艾滋病毒方案的优先事项，包括：与护理的联系，保持护理，坚持抗逆转录病毒治疗。在技术功能方面，mHealth工具促进了警报和提醒，数据收集，直接语音通信，教育消息传递，按需提供信息等。研究大多是描述性的，越来越多的准实验和实验设计。缺乏使用移动保健工具来满足关键人群需求的证据，包括孕妇、性工作者、注射毒品使用者和男男性行为者。针对艾滋病毒的移动健康的科学和实践正在迅速发展，但仍处于早期阶段。小规模的努力、试点项目和初步的描述性研究正在推进，实施移动医疗创新是一个有希望的趋势，在低资源环境、积极的项目成果、运营改进和严格的研究设计中是可行和可接受的。
This systematic review assesses the published literature to describe the landscape of mobile health technology (mHealth) for HIV/AIDS and the evidence supporting the use of these tools to address the HIV prevention, care, and treatment cascade. The speed of innovation, broad range of initiatives and tools, and heterogeneity in reporting have made it difficult to uncover and synthesize knowledge on how mHealth tools might be effective in addressing the HIV pandemic. To do address this gap, a team of reviewers collected literature on the use of mobile technology for HIV/AIDS among health, engineering, and social science literature databases and analyzed a final set of 62 articles. Articles were systematically coded, assessed for scientific rigor, and sorted for HIV programmatic relevance. The review revealed evidence that mHealth tools support HIV programmatic priorities, including: linkage to care, retention in care, and adherence to antiretroviral treatment. In terms of technical features, mHealth tools facilitate alerts and reminders, data collection, direct voice communication, educational messaging, information on demand, and more. Studies were mostly descriptive with a growing number of quasi-experimental and experimental designs. There was a lack of evidence around the use of mHealth tools to address the needs of key populations, including pregnant mothers, sex workers, users of injection drugs, and men who have sex with men. The science and practice of mHealth for HIV are evolving rapidly, but still in their early stages. Small-scale efforts, pilot projects, and preliminary descriptive studies are advancing and there is a promising trend toward implementing mHealth innovation that is feasible and acceptable within low-resource settings, positive program outcomes, operational improvements, and rigorous study design